Trial Profile
A randomized controlled trial of patients with obsessive-compulsive disorder: A functional magnetic resonance imaging study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Fluvoxamine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 23 Feb 2009 New trial record.